The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.
 
Heloisa P. Soares
No Relationships to Disclose
 
Nishi Kothari
No Relationships to Disclose
 
Amit Mahipal
No Relationships to Disclose
 
Gregory M. Springett
No Relationships to Disclose
 
Jongphil Kim
No Relationships to Disclose
 
Fatima Tariq
No Relationships to Disclose
 
Hanna Kelly Sanoff
Consulting or Advisory Role - Amgen
Research Funding - Bayer (Inst); Novartis (Inst)
 
Andrew Stewart Poklepovic
No Relationships to Disclose
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Research Funding - Bayer; Novartis